Cargando…
Establishing a novel prediction model for improving the positive rate of prostate biopsy
BACKGROUND: At present, prostate-specific antigen (PSA) is the primary evaluation index for judging the necessity of prostate cancer (PCa) biopsy. However, there is a high false-positive rate and a low predictive value due to many interference factors. In this study, we tried to find a novel predict...
Autores principales: | Tao, Tao, Shen, Deyun, Yuan, Lei, Zeng, Ailiang, Xia, Kaiguo, Li, Bin, Ge, Qingyu, Xiao, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215001/ https://www.ncbi.nlm.nih.gov/pubmed/32420162 http://dx.doi.org/10.21037/tau.2019.12.42 |
Ejemplares similares
-
Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies
por: Wang, Changming, et al.
Publicado: (2022) -
Construction and Validation of a Clinical Predictive Nomogram for Improving the Cancer Detection of Prostate Naive Biopsy Based on Chinese Multicenter Clinical Data
por: Tao, Tao, et al.
Publicado: (2022) -
Establishment and validation of a prognostic nomogram for patients with renal cell carcinoma based on SEER and TCGA database
por: Wang, Changming, et al.
Publicado: (2023) -
Prostate biopsy approach and complication rates
por: Mate, Kinga, et al.
Publicado: (2023) -
Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy
por: Yoo, Sangjun, et al.
Publicado: (2020)